The aim of this study was to translate and validate chronic liver disease questionnaire (CLDQ) into Bengali using a standard protocol and use it to assess the impact of socioeconomic factors, etiology, disease severity and complications on the quality of life of patients.
Formal translation of CLDQ to Bengali was done. Cronbach’s alpha and test-retest was performed for reliability analysis. Patients with clinically stable chronic liver disease (CLD) without significant associated co-morbid states were administered Bengali CLDQ in the Liver Clinic. The clinical, biochemical and disease parameters were recorded for analysis.
Bengali CLDQ was administered to 100 patients with CLD. Cronbach’s alpha of overall scores was 0.90 and test-retest correlation coefficient of average CLDQ was 0.86 (P < 0.001). Patients with history of decompensation (96.51 vs. 109.61; P = 0.039) and Child’s C status (92.24 vs. 105.71; P = 0.028) had significantly lower CLDQ scores. CLDQ scores showed a moderate inverse correlation with Child’s status (r = −0.35) and a poor correlation with MELD score (r = −0.09).
Bengali translation of CLDQ was found to be reliable. History of decompensation, Child’s C status was associated with worse CLDQ scores. Child’s status may have some role in predicting quality of life of patients with CLD. MELD score had poor predictability of quality of life.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
WHO. Constitution of the World Health Organization. In: World Health Organization. Handbook of basic documents. 5th ed. Geneva: Palais des Nations; 1952. p. 3–20
Chochinov HM, Tataryn D, Clinch JJ, Dudgeon D. Will to live in the terminally ill. Lancet. 1999;354:816–9.
El-Dika S, Guyatt GH, Armstrong D, et al. The impact of illness in patients with moderate to severe gastro-esophageal reflux disease. BMC Gastroenterol. 2005;5:23.
Glise H, Wilklund I. Health-related quality of life and gastrointestinal disease. J Gastroenterol Hepatol. 2002;17(Suppl):S72–S84.
Kanwal F, Hays RD, Kilbourne AM, Dulai GS, Gralnek IM. Are physician-derived disease severity indices associated with health-related quality of life in patients with end-stage liver disease? Am J Gastroenterol. 2004;99:1726–32.
Gralnek IM, Hays RD, Kilbourne A, et al. Development and evaluation of the liver disease quality of life instrument in persons with advanced, chronic liver disease—the LDQOL 1.0. Am J Gastroenterol. 2000;95:3552–65.
Younossi ZM, Guyatt G, Kiwi M, Boparai N, King D. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut. 1999;45:295–300.
Borgaonkar MR, Irvine EJ. Quality of life measurement in gastrointestinal and liver disorders. Gut. 2000;47:444–54.
Younossi ZM, Boparai N, McCormick M, Price LL, Guyatt G. Assessment of utilities and health-related quality of life in patients with chronic liver disease. Am J Gastroenterol. 2001;96:579–83.
Marchesini G, Bianchi G, Amodio P, et al. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology. 2001;120:170–78.
Chong CA, Gulamhussein A, Heathcote EJ, et al. Health-state utilities and quality of life in hepatitis C patients. Am J Gastroenterol. 2003;98:630–38.
Bianchi G, Loguercio C, Sgarbi D, et al. Reduced quality of life of patients with hepatocellular carcinoma. Dig Liver Dis. 2003;35:46–54.
Younossi ZM, Boparai N, Price LL, Kiwi ML, McCormick M, Guyatt G. Health-related quality of life in chronic liver disease: the impact of type and severity of disease. Am J Gastroenterol. 2001;96:2199–205.
Arguedas MR, DeLawrence TG, McGuire BM. Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis. Dig Dis Sci. 2003;48:1622–6.
Cordoba J, Flavia M, Jacas C, et al. Quality of life and cognitive function in hepatitis C at different stages of liver disease. J Hepatol. 2003;39:231–8.
Sobhonslidsuk A, Silpakit C, Kongsakon R, Satitpornkul P, Sripetch C. Chronic liver disease questionnaire: translation and validation in Thais. World J Gastroenterol. 2004;10:1954–7.
Ferrer M, Córdoba J, Garin O, et al. Validity of the Spanish version of the chronic liver disease questionnaire (CLDQ) as a standard outcome for quality of life assessment. Liver Transpl. 2006;12:95–104.
Zuberi BF, Memon AR, Afsar S, Qadeer R, Kumar R. Correlation of quality of life in patients of cirrhosis of liver with etiology and disease severity using disease-specific quality of life questionnaire. J Ayub Med Coll Abottabad. 2007;19:7–11.
Hauser W, Schnur M, Steder-Neukamm U, Muthny FA, Grandt D. Validation of the German version of the chronic liver disease questionnaire. Eur J Gastroenterol Hepatol. 2004;16:599–606.
Tiwari R, Aggarwal A, Devi P. Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency viruses amongst drug users in Amritsar. Indian J Med Microbiol. 2006;24:151–2.
Kawabata K, Xu K, Carrin G. Preventing impoverishment through protection against catastrophic health expenditure. Bull World Health Organ. 2002;80:612.
Scientific Advisory Committee of the Medical Outcomes Trust. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res. 2002;11:193–205.
Lucey MR, Mathurin P, Morgan TR. Alcoholic hepatitis. N Engl J Med. 2009;360:2758–69.
Bland JM, Altman DG. Cronbach’s alpha. BMJ 1997;314:572.
Bergner M, Bobbit RA, Pollard WE, et al. The sickness impact profile: validation of a health status measure. Med Care. 1976;14:57–67.
McSweeny AJ, Creer TL. Health-related quality-of-life assessment in medical care. Dis Mon. 1995;41:1–7l.
Bush JW. General health policy model/quality of well-being (QWB) scale. In: Wenger NK, Mattson ME, Furberg CD, et al. eds. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. New York: LeJacq; 1984. p. 189–99.
Andresen EM, Rothenberg BM, Kaplan RM. Performance of a self-administered mailed version of the quality of well-being (QWB-SA) questionnaire among older adults. Med Care. 1998;36:1349–60.
Stewart AL, Hays RD, Ware JE Jr. The MOS short form general health survey. Reliability and validity in a patient population. Med Care. 1988;26:724–35.
Tarlov AR, Ware JE Jr, Greenfield S, et al. The medical outcomes study: an application of methods for monitoring the effects of medical care. JAMA. 1989;262:925–30.
Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36), I: conceptual framework and item selection. Med Care. 1992;30:473–83.
Kanwal F, Gralnek IM, Hays RD, et al. Spiegel BM Health-related quality of life predicts mortality in patients with advanced chronic liver disease. Clin Gastroenterol Hepatol. 2009;7:793–9.
Younossi Z, Kallman J, Kincaid J. The effects of HCV infection and management on health-related quality of life. Hepatology. 2007;45:806–16.
Marcellin P, Lau GK, Zeuzem S, et al. Comparing the safety, tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peginterferon alpha-2a. Liver Int. 2008;28:477–85.
The authors would like to acknowledge Younossi ZM et al. for giving permission to adapt CLDQ to Bengali. This study has not been funded.
Pallavi Basu is presently working with McKinsey & Co., Gurgaon, India.
About this article
Cite this article
Ray, I., Dutta, D., Basu, P. et al. Quality of life assessment of patients with chronic liver disease in eastern India using a Bengali translation chronic liver disease questionnaire. Indian J Gastroenterol 29, 187–195 (2010). https://doi.org/10.1007/s12664-010-0036-x
- Alcoholic liver disease
- Chronic hepatitis B
- Chronic hepatitis C
- Quality of life